110 related articles for article (PubMed ID: 14567289)
1. Effects of etherlipid analogs on cell membrane functions.
Berkovic D; Wernicke JH; Fleer EA
J Exp Ther Oncol; 2003; 3(4):185-93. PubMed ID: 14567289
[TBL] [Abstract][Full Text] [Related]
2. Effects of hexadecylphosphocholine on membrane phospholipid metabolism in human tumour cells.
Berkovic D; Grunwald U; Menzel W; Unger C; Hiddemann W; Fleer EA
Eur J Cancer; 1995 Nov; 31A(12):2080-5. PubMed ID: 8562169
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic effects of hexadecylphosphocholine in neoplastic cell lines including drug-resistant sublines in vitro.
Danhauser-Riedl S; Himmelmann A; Steinhauser G; Busch R; Vogler WR; Rastetter J; Berdel WE
J Lipid Mediat; 1990; 2(5):271-80. PubMed ID: 2133272
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic etherphospholipid analogues.
Berkovic D
Gen Pharmacol; 1998 Oct; 31(4):511-7. PubMed ID: 9792208
[TBL] [Abstract][Full Text] [Related]
5. Synergistic cytotoxic effects of ether phospholipid analogues and ionizing radiation in human carcinoma cells.
Berkovic D; Gründel O; Berkovic K; Wildfang I; Hess CF; Schmoll HJ
Radiother Oncol; 1997 Jun; 43(3):293-301. PubMed ID: 9215791
[TBL] [Abstract][Full Text] [Related]
6. Induction of resistance to hexadecylphosphocholine in the highly sensitive human epidermoid tumour cell line KB.
Fleer EA; Berkovic D; Grunwald U; Hiddemann W
Eur J Cancer; 1996 Mar; 32A(3):506-11. PubMed ID: 8814699
[TBL] [Abstract][Full Text] [Related]
7. Acquisition of human concentrative nucleoside transporter 2 (hcnt2) activity by gene transfer confers sensitivity to fluoropyrimidine nucleosides in drug-resistant leukemia cells.
Lang TT; Selner M; Young JD; Cass CE
Mol Pharmacol; 2001 Nov; 60(5):1143-52. PubMed ID: 11641443
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of calcium-dependent protein kinase C by hexadecylphosphocholine and 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine do not correlate with inhibition of proliferation of HL60 and K562 cell lines.
Berkovic D; Berkovic K; Fleer EA; Eibl H; Unger C
Eur J Cancer; 1994; 30A(4):509-15. PubMed ID: 8018410
[TBL] [Abstract][Full Text] [Related]
9. Expression of two 50 kDa proteins is associated with sensitivity towards etherlipid analogues in the human leukaemia cell line HL 60.
Berkovic D; Hiddemann W; Kuduz J; Fleer EA
Eur J Cancer; 1997 Oct; 33(11):1875-80. PubMed ID: 9470850
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of cellular transport systems by alkyl phospholipid analogs in HL-60 human leukemia cells.
Hoffman DR; Thomas VL; Snyder F
Biochim Biophys Acta; 1992 Jul; 1127(1):74-80. PubMed ID: 1627636
[TBL] [Abstract][Full Text] [Related]
11. The antiproliferative effect of hexadecylphosphocholine toward HL60 cells is prevented by exogenous lysophosphatidylcholine.
Boggs K; Rock CO; Jackowski S
Biochim Biophys Acta; 1998 Jan; 1389(1):1-12. PubMed ID: 9443598
[TBL] [Abstract][Full Text] [Related]
12. Effects of hexadecylphosphocholine on phosphatidylcholine and phosphatidylserine metabolism in human lymphoma cells.
Berkovic D; Sievers S; Haase D; Fleer EA; Binder C
J Exp Ther Oncol; 2002; 2(2):85-92. PubMed ID: 12415624
[TBL] [Abstract][Full Text] [Related]
13. Decreased sensitivity to 1-O-octadecyl-2-O-methyl-glycerophosphocholine in MCF-7 cells adapted for serum-free growth correlates with constitutive association of Raf-1 with cellular membranes.
Samadder P; Arthur G
Cancer Res; 1999 Oct; 59(19):4808-15. PubMed ID: 10519389
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationships of antineoplastic ring-substituted ether phospholipid derivatives.
Papazafiri P; Avlonitis N; Angelou P; Calogeropoulou T; Koufaki M; Scoulica E; Fragiadaki I
Cancer Chemother Pharmacol; 2005 Sep; 56(3):261-70. PubMed ID: 15856232
[TBL] [Abstract][Full Text] [Related]
15. HL-60 cells become resistant towards antitumor ether-linked phospholipids following differentiation into a granulocytic form.
Vallari DS; Smith ZL; Snyder F
Biochem Biophys Res Commun; 1988 Oct; 156(1):1-8. PubMed ID: 3178823
[TBL] [Abstract][Full Text] [Related]
16. Anticancer mechanisms and clinical application of alkylphospholipids.
van Blitterswijk WJ; Verheij M
Biochim Biophys Acta; 2013 Mar; 1831(3):663-74. PubMed ID: 23137567
[TBL] [Abstract][Full Text] [Related]
17. Membrane transport of macromolecules: new carrier functions of proteins and poly(amino acids).
Ryser HJ; Shen WC; Merk FB
Life Sci; 1978 Apr 3-17; 22(13-15):1253-60. PubMed ID: 351319
[No Abstract] [Full Text] [Related]
18. Resistance to the new anti-cancer phospholipid ilmofosine (BM 41 440).
Hofmann J; Utz I; Spitaler M; Hofer S; Rybczynska M; Beck WT; Herrmann DB; Grunicke H
Br J Cancer; 1997; 76(7):862-9. PubMed ID: 9328144
[TBL] [Abstract][Full Text] [Related]
19. Impairment of erbB1 receptor and fluid-phase endocytosis and associated mitogenic signaling by inositol hexaphosphate in human prostate carcinoma DU145 cells.
Zi X; Singh RP; Agarwal R
Carcinogenesis; 2000 Dec; 21(12):2225-35. PubMed ID: 11133812
[TBL] [Abstract][Full Text] [Related]
20. Is metabolism an important arbiter of anticancer activity of ether lipids? Metabolism of SRI 62-834 and hexadecylphosphocholine by [31P]-NMR spectroscopy and comparison of their cytotoxicities with those of their metabolites.
Bishop FE; Dive C; Freeman S; Gescher A
Cancer Chemother Pharmacol; 1992; 31(2):85-92. PubMed ID: 1451237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
